• News
  • FAQ
  • Investors
JanOne
  • Why We Exist
  • Pipeline
  • The Pain Truth
  • About PAD
  • Our Company
  • News
  • FAQ
  • Investors
  • FOLLOW THE PROGRESS

Quote

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Shareholder Letter
    • FAQ
  • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact Us

  • Stock Data

  • Quote
  • Charts
  • Historical Data
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
JanOne

JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a result, we hope to reduce the need for prescribing dangerous opioid drugs. Our first drug candidate is a treatment for Peripheral Arterial Disease (PAD), a condition that can cause severe pain and affects over 8.5 million people in the US alone.

The company trades under the symbol JAN on the NASDAQ and continues to independently operate its subsidiary business – Appliance Recycling Centers of America, Inc (ARCA).

Latest News

JanOne on Twitter
  • Why We Exist
  • Pipeline
  • The Pain Truth
  • About PAD
  • Our Company
  • News
  • FAQs
  • Investors
  • Contact

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.